GPSM1 (NM_001145639) Human Tagged ORF Clone Lentiviral Particle
CAT#: RC227685L3V
- LentiORF®
-
Lenti ORF particles, GPSM1 (Myc-DDK-tagged)-Human G-protein signaling modulator 1 (GPSM1), transcript variant 3, 200ul, >10^7 TU/mL
Need custom lentivirus service?
Get a free quote
CNY 7,410.00
货期*
详询
规格
Product images
![](https://cdn.origene.com/img/defaults-img.jpg)
经常一起买 (3)
Specifications
Product Data | |
Product Name | GPSM1 (NM_001145639) Human Tagged ORF Clone Lentiviral Particle |
Synonyms | AGS3 |
Vector | pLenti-C-Myc-DDK-P2A-Puro |
ACCN | NM_001145639 |
ORF Size | 498 bp |
Sequence Data |
The ORF insert of this clone is exactly the same as(RC227685).
|
OTI Disclaimer | The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info |
OTI Annotation | This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. |
Reference Data | |
RefSeq | NM_001145639.1, NP_001139111.1 |
RefSeq ORF | 501 bp |
Locus ID | 26086 |
MW | 17.8 kDa |
Gene Summary | G-protein signaling modulators (GPSMs) play diverse functional roles through their interaction with G-protein subunits. This gene encodes a receptor-independent activator of G protein signaling, which is one of several factors that influence the basal activity of G-protein signaling systems. The protein contains seven tetratricopeptide repeats in its N-terminal half and four G-protein regulatory (GPR) motifs in its C-terminal half. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011] |
Documents
Product Manuals |
FAQs |
SDS |
Resources
You may also need
Customer
Reviews
Loading...